130 related articles for article (PubMed ID: 37182451)
1. Cisatracurium besylate rescues Mycobacterium Tuberculosis-infected macrophages from necroptosis and enhances the bactericidal effect of isoniazid.
Wen Q; Zhang J; Zhang Z; Chen L; Liu H; Han Z; Chen Y; Wang K; Liu J; Sai N; Zhou X; Zhou C; Hu S; Ma L
Int Immunopharmacol; 2023 Jul; 120():110291. PubMed ID: 37182451
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of Mycobacterium tuberculosis-infected host cells to phospho-MLKL driven necroptosis is dependent on cell type and presence of TNFα.
Butler RE; Krishnan N; Garcia-Jimenez W; Francis R; Martyn A; Mendum T; Felemban S; Locker N; Salguero FJ; Robertson B; Stewart GR
Virulence; 2017 Nov; 8(8):1820-1832. PubMed ID: 28892415
[TBL] [Abstract][Full Text] [Related]
3. Dimethyl fumarate inhibits necroptosis and alleviates systemic inflammatory response syndrome by blocking the RIPK1-RIPK3-MLKL axis.
Shi FL; Yuan LS; Wong TS; Li Q; Li YP; Xu R; You YP; Yuan T; Zhang HR; Shi ZJ; Zha QB; Hu B; He XH; Ouyang DY
Pharmacol Res; 2023 Mar; 189():106697. PubMed ID: 36796462
[TBL] [Abstract][Full Text] [Related]
4. RIPK1 inhibits ZBP1-driven necroptosis during development.
Newton K; Wickliffe KE; Maltzman A; Dugger DL; Strasser A; Pham VC; Lill JR; Roose-Girma M; Warming S; Solon M; Ngu H; Webster JD; Dixit VM
Nature; 2016 Dec; 540(7631):129-133. PubMed ID: 27819682
[TBL] [Abstract][Full Text] [Related]
5. Opposite Effects of Apoptotic and Necroptotic Cellular Pathways on Rotavirus Replication.
Soliman M; Seo JY; Baek YB; Park JG; Kang MI; Cho KO; Park SI
J Virol; 2022 Jan; 96(1):e0122221. PubMed ID: 34668777
[TBL] [Abstract][Full Text] [Related]
6. NAD
Pajuelo D; Gonzalez-Juarbe N; Tak U; Sun J; Orihuela CJ; Niederweis M
Cell Rep; 2018 Jul; 24(2):429-440. PubMed ID: 29996103
[TBL] [Abstract][Full Text] [Related]
7. Necroptotic signaling is primed in Mycobacterium tuberculosis-infected macrophages, but its pathophysiological consequence in disease is restricted.
Stutz MD; Ojaimi S; Allison C; Preston S; Arandjelovic P; Hildebrand JM; Sandow JJ; Webb AI; Silke J; Alexander WS; Pellegrini M
Cell Death Differ; 2018 May; 25(5):951-965. PubMed ID: 29229989
[TBL] [Abstract][Full Text] [Related]
8. Celastrol inhibits necroptosis by attenuating the RIPK1/RIPK3/MLKL pathway and confers protection against acute pancreatitis in mice.
Liang QQ; Shi ZJ; Yuan T; Chen SY; Li YP; Zhang HR; You YP; Xu R; Xu LH; Hu B; Ouyang DY; Zha QB; He XH
Int Immunopharmacol; 2023 Apr; 117():109974. PubMed ID: 37012867
[TBL] [Abstract][Full Text] [Related]
9. RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation.
Lin J; Kumari S; Kim C; Van TM; Wachsmuth L; Polykratis A; Pasparakis M
Nature; 2016 Dec; 540(7631):124-128. PubMed ID: 27819681
[TBL] [Abstract][Full Text] [Related]
10. RIPK1-RIPK3-MLKL-Associated Necroptosis Drives
Barbosa LA; Fiuza PP; Borges LJ; Rolim FA; Andrade MB; Luz NF; Quintela-Carvalho G; Lima JB; Almeida RP; Chan FK; Bozza MT; Borges VM; Prates DB
Front Immunol; 2018; 9():1818. PubMed ID: 30154785
[TBL] [Abstract][Full Text] [Related]
11. Tyramide Signal Amplification for the Immunofluorescent Staining of ZBP1-dependent Phosphorylation of RIPK3 and MLKL After HSV-1 Infection in Human Cells.
Nemegeer J; Lemeire K; Vandenabeele P; Maelfait J
J Vis Exp; 2022 Oct; (188):. PubMed ID: 36342164
[TBL] [Abstract][Full Text] [Related]
12. A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis.
Fauster A; Rebsamen M; Huber KV; Bigenzahn JW; Stukalov A; Lardeau CH; Scorzoni S; Bruckner M; Gridling M; Parapatics K; Colinge J; Bennett KL; Kubicek S; Krautwald S; Linkermann A; Superti-Furga G
Cell Death Dis; 2015 May; 6(5):e1767. PubMed ID: 25996294
[TBL] [Abstract][Full Text] [Related]
13. Z-DNA/RNA Binding Protein 1 Senses Mitochondrial DNA to Induce Receptor-Interacting Protein Kinase-3/Mixed Lineage Kinase Domain-Like-Driven Necroptosis in Developmental Sevoflurane Neurotoxicity.
Wang WY; Yi WQ; Liu YS; Hu QY; Qian SJ; Liu JT; Mao H; Cai F; Yang HL
Neuroscience; 2022 Dec; 507():99-111. PubMed ID: 36370933
[TBL] [Abstract][Full Text] [Related]
14. FKBP12 mediates necroptosis by initiating RIPK1-RIPK3-MLKL signal transduction in response to TNF receptor 1 ligation.
Wang Z; Feng J; Yu J; Chen G
J Cell Sci; 2019 May; 132(10):. PubMed ID: 31028177
[TBL] [Abstract][Full Text] [Related]
15. Metabolic changes enhance necroptosis of type 2 diabetes mellitus mice infected with Mycobacterium tuberculosis.
Vankayalapati A; Durojaye O; Mukherjee T; Paidipally P; Owusu-Afriyie B; Vankayalapati R; Radhakrishnan RK
PLoS Pathog; 2024 May; 20(5):e1012148. PubMed ID: 38728367
[TBL] [Abstract][Full Text] [Related]
16. RIPK3-MLKL-mediated necroinflammation contributes to AKI progression to CKD.
Chen H; Fang Y; Wu J; Chen H; Zou Z; Zhang X; Shao J; Xu Y
Cell Death Dis; 2018 Aug; 9(9):878. PubMed ID: 30158627
[TBL] [Abstract][Full Text] [Related]
17. The Lck inhibitor, AMG-47a, blocks necroptosis and implicates RIPK1 in signalling downstream of MLKL.
Jacobsen AV; Pierotti CL; Lowes KN; Au AE; Zhang Y; Etemadi N; Fitzgibbon C; Kersten WJA; Samson AL; van Delft MF; Huang DCS; Sabroux HJ; Lessene G; Silke J; Murphy JM
Cell Death Dis; 2022 Apr; 13(4):291. PubMed ID: 35365636
[TBL] [Abstract][Full Text] [Related]
18. Caspase-8, receptor-interacting protein kinase 1 (RIPK1), and RIPK3 regulate retinoic acid-induced cell differentiation and necroptosis.
Someda M; Kuroki S; Miyachi H; Tachibana M; Yonehara S
Cell Death Differ; 2020 May; 27(5):1539-1553. PubMed ID: 31659279
[TBL] [Abstract][Full Text] [Related]
19. The neurotoxicant PCB-95 by increasing the neuronal transcriptional repressor REST down-regulates caspase-8 and increases Ripk1, Ripk3 and MLKL expression determining necroptotic neuronal death.
Guida N; Laudati G; Serani A; Mascolo L; Molinaro P; Montuori P; Di Renzo G; Canzoniero LMT; Formisano L
Biochem Pharmacol; 2017 Oct; 142():229-241. PubMed ID: 28676433
[TBL] [Abstract][Full Text] [Related]
20. Ligustroflavone reduces necroptosis in rat brain after ischemic stroke through targeting RIPK1/RIPK3/MLKL pathway.
Zhang YY; Liu WN; Li YQ; Zhang XJ; Yang J; Luo XJ; Peng J
Naunyn Schmiedebergs Arch Pharmacol; 2019 Sep; 392(9):1085-1095. PubMed ID: 31055628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
